NK-Cell Leukemia: Clinical Trials

3 trials for NK-Cell Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 unknown. 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Unknown 1
Early Phase 11Recruiting 1

Follow NK-Cell Leukemia: new trials by email Literature Review of NK-Cell Leukemia trials Research Report on NK-Cell Leukemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia
Anti-CD56 CAR T - Extranodal NK T Cell Lymphoma, NK-Cell Leukemia
Phase 2UnknownThe Affiliated Hospital of Xuzhou Medical University202023-05-012023-07-12
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
Methotrexate, pralatraxate,, Ifosfamide - NK-Cell Lymphoma, NK-Cell Leukemia
Early Phase 1RecruitingNew York Medical College402019-03-012026-08-18
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
Cyclophosphamide, Fludarabine, Thiotepa - Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML)
Phase 2Active not recruitingSt. Jude Children's Research Hospital692019-01-312026-09-15

Narrower conditions

Leukemia, Large Granular Lymphocytic (3)  ·  Hodgkin Disease (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Juvenile (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell, Peripheral (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Leukemia (3)  ·  Leukemia, Lymphoid (3)  ·  Leukemia, T-Cell (3)  ·  Lymphatic Diseases (3)  ·  Lymphoma (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoma, T-Cell (2)  ·  Bone Marrow Diseases (1)

Interventions

Cyclophosphamide (2)  ·  Brentuximab Vedotin (1)  ·  Dexamethasone (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Ifosfamide (1)  ·  Melphalan (1)  ·  Mesna (1)  ·  Methotrexate (1)  ·  Prednisone (1)  ·  Thiotepa (1)  ·  blinatumomab (1)  ·  calaspargase pegol (1)

Sponsors

New York Medical College (1)  ·  St. Jude Children's Research Hospital (1)  ·  The Affiliated Hospital of Xuzhou Medical University (1)

Countries

United States (2)  ·  China (1)

Top investigators

Brandon Triplett, MD (1)  ·  Mitchell Cairo, MD (1)